Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs?

Fertility and Sterility

Volumn 88, Issue 5, 2007, Pages 1437.e5-1437.e11

  Ezquieta, Begoña ^a   Alonso, Milagros ^b   Alvarez, Eduardo ^c   Arnao, Dolores R ^a   Rodríguez, Amparo ^a   Siguero, Juan P L ^d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

21 hydroxylase deficiency; Assisted reproductive technology; carrier detection; in vitro fertilization

Indexed keywords

CORTICOTROPIN; DNA; FLUDROCORTISONE; HYDROCORTISONE; SODIUM CHLORIDE; STEROID 21 MONOOXYGENASE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME DEFICIENCY; FAMILY STUDY; FEMALE; FERTILIZATION IN VITRO; GENE MUTATION; GENOTYPE; HUMAN; INFERTILITY THERAPY; MALE; PARENT; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALT LOSING NEPHRITIS; SIBLING; SOUTHERN BLOTTING; STEROID THERAPY; VIRILIZATION;

EID: 35648950610     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.030     Document Type: Article

References (26)

1. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Endoc Rev 21 (2000) 245-291
2. Speiser PW, White PC. Congenital adrenal hyperplasia. N Eng J Med 349:776-88.
3. Merke D.P., and Bornstein S.R. Congenital adrenal hyperplasia. Lancet 365 (2005) 2125-2136
4. New M.I. Nonclassic 21-hydroxylase deficiency. Fertil Steril 86 Suppl 1 (2006) S2
5. Speiser P.W., Knochenhauer E.S., Dewailly D., Frizzetti F., Marcondes J.A., and Azziz R. A multicenter study of women with nonclassic congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 71 (2000) 527-534
6. Bachega T.A.S.S., Billerbeck A.E.C., Marcondes J.A.M., Madureira G., Arnhold I.J.P., and Mendonca B.B. 2000. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 52 (2000) 601-607
7. Dracopoulou-Vabouli M., Maniati-Christidi M., and Dacou-Voutetakis C. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 86 (2001) 2845-2848
8. Ezquieta B., Cueva E., Varela J., Oliver A., Fernández J., and Jariego C. Nonclassical 21-hydroxylase deficiency in children: association of ACTH-stimulated 17OH progesterone with risk for compound heterozygosity for severe mutations. Acta Paediatr 91 (2002) 892-898
9. Yang R.M., Fefferman R.A., and Shapiro C.E. Reversible infertility in a man with 21-hydroxylase deficiency congenital adrenal hyperplasia. Fertil Steril 83 (2005) 223-225
10. Grody W.W., Cutting G.R., Klinger K.W., Richards C.S., Watson M.S., and Desnick R.J. Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee. ACMG American College of Medical Genetics: laboratory standards guidelines for population-based cystic fibrosis carrier screening. Genet Med 3 (2001) 149-154
11. Lewis-Jones D.I., Gazvani M.R., and Mountford R. Cystic fibrosis in infertility: screening before assisted reproduction. Hum Reprod 15 (2000) 2415-2417
12. Wong L.J., Alpèr O.M., Hsu E., Woo M.S., and Margetis M.F. The necessity of complete CFTR mutational analysis of an infertile couple before in vitro fertilization. Fertil Steril 82 (2004) 47-49
13. Zenke U., and Chetkowski R.J. Inclusion of heterozygotes for cystic fibrosis in the egg donor pool. Fertil Steril 78 (2002) 557-561
14. Ezquieta B., Oliver A., Gracia R., and Gancedo P.G. Analysis of steroid 21-Hydroxylase mutations in the Spanish population. Hum Genet 96 (1995) 198-204
15. Ezquieta B., Beneyto M., Muñoz-Pacheco R., Barrio R., Oyarzabal M., Lechuga J.L., et al. Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis. Prenat Diagn 26 (2006) 1172-1178
16. Ezquieta B., Varela J.M., Jariego C., Oliver A., and Gracia R. Nonisotopic detection of point mutations in CYP21B gene in steroid 21-hydroxylase deficiency. Clin Chem 42 (1996) 1108-1110
17. Ezquieta B., Oyarzábal M., Jariego C.M., Varela J.M., and Chueca M. A novel frameshift in the first exon of the 21-OH gene found in homozygosity in an apparently nonconsanguineous family. Horm Res 51 (1999) 135-141
18. Ezquieta B., Cueva E., Oyarzabal M., Oliver A., Varela J., and Jariego C. Gene conversion (655 splicing mutation) and the founder effect (Q318X) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia in the Spanish population. Clin Genet 62 (2002) 181-188
19. Ezquieta B., Jariego C.M., Varela J.M., Oliver A., and Gracia R. Microsatellite typing in the indirect analysis of steroid 21-hydroxylase gene. Prenat Diagn 17 (1997) 429-434
20. Gazvani R., and Lewis-Jones I. Cystic fibrosis screening in assisted reproduction. Curr Opin Obstet Gynecol 18 (2006) 268-272
21. Baumgartner-Parzer S.M., Nowotny P., Heinze G., Waldhausl W., and Vierhapper H. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 90 (2005) 775-778
22. Fitness J., Dixit N., Webster D., Torresani T., Pergolizzi R., Speiser P.W., et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 84 (1999) 960-966
23. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87 (2002) 4048-4053
24. Koppens P.F., Hoogenboezem T., and Degenhart H.J. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet 111 (2002) 405-410
25. Ezquieta B., Ruano M.L., Dulín E., Arnao D.R., and Rodríguez A. Prevalence of frequent recessive diseases in the Spanish population through DNA analyses on samples from the neonatal screening. Med Clin (Barc) 125 (2005) 493-495
26. Schrijver I., Oitmaa E., Metspalu A., and Gardner P. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations. J Mol Diagn 3 (2005) 375-387